Solara Active Pharma Sciences Limited (BOM:890202)

BOM:890202 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	32,987	20,499	24,661	13,353	11,787	23,977
Market Cap Growth	11.19%	-16.88%	84.69%	13.28%	-50.84%	-52.10%
Enterprise Value	39,346	26,948	33,026	23,165	21,509	31,550
Last Close Price	308.70	273.50	261.00	-	-	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	-	-	4566.82	-	-	-
PS Ratio	2.30	1.50	1.92	1.04	0.82	1.89
PB Ratio	2.63	1.63	2.25	1.43	0.79	1.57
P/TBV Ratio	3.81	2.37	3.53	2.54	1.09	2.20
P/FCF Ratio	32.96	20.48	14.27	19.69	26.23	-
P/OCF Ratio	21.57	13.41	11.59	12.27	7.54	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.75	1.97	2.57	1.80	1.49	2.49
EV/EBITDA Ratio	20.73	14.78	16.29	-	16.36	39.77
EV/EBIT Ratio	44.26	30.57	30.57	-	77.96	-
EV/FCF Ratio	39.31	26.92	19.10	34.16	47.86	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.55	0.55	0.73	1.08	0.67	0.68
Debt / EBITDA Ratio	3.62	3.69	3.87	-	7.55	12.63
Debt / FCF Ratio	-	6.86	4.61	14.92	22.54	-
Net Debt / Equity Ratio	0.50	0.54	0.72	1.07	0.67	0.65
Net Debt / EBITDA Ratio	3.34	3.72	3.91	-10.24	7.64	12.49
Net Debt / FCF Ratio	-	6.79	4.58	14.79	22.34	-2.20
Asset Turnover	-	0.60	0.56	0.49	0.49	0.46
Inventory Turnover	-	2.31	1.95	1.88	1.48	1.63
Quick Ratio	-	0.53	0.41	0.33	0.53	0.56
Current Ratio	-	0.96	0.77	0.64	1.08	1.17
Return on Equity (ROE)	-	-0.63%	0.05%	-46.49%	-1.47%	-3.74%
Return on Assets (ROA)	-	2.41%	2.95%	-4.70%	0.59%	-0.58%
Return on Invested Capital (ROIC)	4.65%	4.61%	5.64%	-8.89%	1.10%	-1.15%
Return on Capital Employed (ROCE)	-	6.10%	8.40%	-17.80%	1.50%	-1.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-0.05%	-0.36%	0.02%	-42.49%	-1.88%	-2.43%
FCF Yield	3.03%	4.88%	7.01%	5.08%	3.81%	-18.80%
Buyback Yield / Dilution	-13.50%	-10.44%	-4.44%	-6.13%	-0.15%	-4.75%
Total Shareholder Return	-13.50%	-10.44%	-4.44%	-6.13%	-0.15%	-4.75%

Data Source: S&P Global Market Intelligence Last updated: Jul 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 4, 2026

Data Sources Report a data error